Pura Vida Investments’s Bristol-Myers Squibb BMY Stock Holding History

Pura Vida Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100,000	Closed	-$6.03M	–	186
2020 Q3	$6.03M	Sell	100,000 -206,000	-67%	-$12.4M	0.31%	65
2020 Q2	$18M	Buy	+306,000	New	+$18.3M	1.73%	16
2019 Q2	–	Sell	-100,000	Closed	-$4.77M	–	104
2019 Q1	$4.77M	Buy	+100,000	New	+$4.98M	0.68%	45
2018 Q2	–	Sell	-100,000	Closed	-$6.33M	–	97
2018 Q1	$6.33M	Buy	+100,000	New	+$6.43M	3.74%	6
2017 Q4	–	Sell	-100,000	Closed	-$6.37M	–	75
2017 Q3	$6.37M	Buy	+100,000	New	+$5.84M	1.87%	15

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's BMY Position: Q4 2020 in Review

Pura Vida Investments sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 87,469 shares — an estimated $5.27M sold.

Pura Vida Investments first reported a position in BMY in Q2 2015 and held it in 6 quarters. The position peaked at $6.34M in Q2 2016. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Pura Vida Investments reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
Pura Vida Investments sold 87,469 Bristol-Myers Squibb shares in Q4 2020, an estimated $5.27M.
Pura Vida Investments first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 6 quarters.
Pura Vida Investments's Bristol-Myers Squibb position peaked at $6.34M in Q2 2016.
2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.